Table 2

Baseline characteristics, clinical presentation, and outcome of diabetic patients with KPLA according to different HbA1c levels
Factor HbA1c < 7% (n = 19) HbA1c = 7 ~ 10% (n = 44) HbA1c >; 10% (n = 39) p value p value, (adjusted age)
Male 12 (63.2) 30 (68.2) 29 (74.4) 0.660 0.999
Age in years 71.3 ± 9.9 68.2 ± 11.4 56.3 ±15.8 <0.001
Underlying diseases
 Malignancy 1 (5.6) 8 (20.0) 2 (5.1) 0.100 0.560
 Alcoholism 1 (5.3) 0 (0) 4 (10.3) 0.081 0.378
 Chronic kidney disease 1 (5.6) 7 (17.5) 1 (2.6) 0.067 0.889
 Liver cirrhosis 0 (0) 2 (4.5) 0 (0) 0.667 0.676
 Congestive heart failure 0 (0) 2 (4.5) 0 (0) 0.667 0.970
 Chronic lung disease 0 (0) 1 (2.3) 0 (0) 1.000 0.979
Newly diagnosed diabetes 4 (21.1) 6 (13.6) 15 (38.5) 0.028 0.146
Origin
 Cryptogenic 15 (78.9) 38 (86.4) 39 (100.0) 0.008 0.008
 Biliary tract origin 1 (5.3) 5 (11.4) 0 (0) 0.068 0.287
Abscess locations
 Right lobe 11 (57.9) 23 (52.3) 21 (53.8) 0.442 0.214
 Left lobe 5 (26.3) 13 (29.5) 6 (15.4)
 Both lobes 3 (15.8) 8 (18.2) 12 (30.8)
Abscess size
 < 5 cm 9 (47.4) 18 (40.9) 18 (46.2) 0.962 0.829
 5 ~ 10 cm 9 (47.4) 21 (47.7) 18 (46.2)
 >; 10 cm 1 (5.3) 5 (11.4) 3 (7.7)
Gas forming 0 (0) 6 (13.6) 6 (15.4) 0.218 0.317
Multiple abscesses 8 (42.1) 12 (27.3) 17 (43.6) 0.256 0.308
Initial laboratory value
 Leukocyte count, × 103/μL 12.4 ± 3.8 14.4 ± 5.6 12.4 ± 6.2 0.168 0.225
 Platelet, × 103/μL 195 ± 87 222 ± 102 237 ± 140 0.380 0.734
 C-reactive protein, mg/dL 18.8 ± 9.2 19.3 ± 9.6 20.9 ± 10.1 0.539 0.826
 Glucose, mg/dL 193 ± 76 270 ± 152 371 ± 170 <0.001 <0.001
Treatment
 Antibiotics + drainage 16 (84.2) 37 (84.1) 32 (82.1) 1.000 0.779
 Antibiotics + operation 1 (5.3) 2 (4.5) 1 (2.6) 1.000 0.345
 Antibiotics only 2 (10.5) 6 (13.6) 5 (13.2) 1.000 0.524
Metastatic infections, 0 (0) 3 (6.8) 9 (23.1) 0.021 0.004
Outcome
 Hospitalization days 26.3 ± 15.7 31.9 ± 23.2 24.9 ± 12.5 0.201 0.265
 ICU admission 2 (10.5) 5 (11.4) 7 (17.9) 0.695 0.605
 Mortality 0 (0) 1 (2.3) 2 (5.1) 0.785 0.181

Data are presented as mean ± SD or frequency with percentage (%).

Lin et al.

Lin et al. BMC Infectious Diseases 2013 13:56   doi:10.1186/1471-2334-13-56

Open Data